الصفحة الرئيسية>>Signaling Pathways>> GPCR/G protein>> GPR119>>PSN632408

PSN632408

رقم الكتالوجGC10365

يُظهر PSN632408 ، وهو ناهض GPR119 انتقائي نشط عن طريق الفم ، فاعلية مماثلة لـ OEA في كل من الفئران المؤتلفة ومستقبلات GPR119 البشرية (EC50 = 5.6 و 7.9 ميكرومتر ، على التوالي)

Products are for research use only. Not for human use. We do not sell to patients.

PSN632408 التركيب الكيميائي

Cas No.: 857652-30-3

الحجم السعر المخزون الكميّة
5mg
60٫00
Ship Within 10-14 Days
10mg
98٫00
Please Inquire
50mg
439٫00
Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PSN632408 is a novel, selective and small-molecule agonist of human and mouse GPR119 with EC50 values of 5.6±0.99 μM and 7.9±0.7 μM, respectively [1].

PSN632408 has been reported to activate human and mouse GPR119 in a yeast fluorimetric assay with EC50 of 5.6±0.99 μM and 7.9±0.7 μM, respectively. In HEK-OSGPR116 cells, cAMP level was dose-dependently increased by PSN632408 with an EC50 of 1.9±0.14 μM.. In vivo, PSN632408 induced food intake reduction by using a rat feeding model and acute hypophagic effects in dose-dependence [1].

References:
[1] Overton HA1, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, Tang-Christensen M, Widdowson PS, Williams GM, Reynet C.Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006 Mar;3(3):167-75

مراجعات

Review for PSN632408

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PSN632408

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.